Fleaborne Typhus-Associated Deaths - Los Angeles County, California, 2022.


Journal

MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429

Informations de publication

Date de publication:
04 Aug 2023
Historique:
medline: 7 8 2023
pubmed: 3 8 2023
entrez: 3 8 2023
Statut: epublish

Résumé

Fleaborne typhus (also known as murine typhus), a widely distributed vectorborne zoonosis caused by Rickettsia typhi, is a moderately severe, but infrequently fatal illness; among patients who receive doxycycline, the case-fatality rate is <1%. Fleaborne typhus is a mandated reportable condition in California. Reported fleaborne typhus cases in Los Angeles County have been increasing since 2010, with the highest number (171) reported during 2022. During June-October 2022, Los Angeles County Department of Public Health learned of three fleaborne typhus-associated deaths. This report describes the clinical presentation, illness course, and methods used to diagnose fleaborne typhus in these three cases. Severe fleaborne typhus manifestations among these cases included hemophagocytic lymphohistiocytosis, a rare immune hyperactivation syndrome that can occur in the infection setting; myocarditis; and septic shock with disseminated intravascular coagulation. Increased health care provider and public health awareness of the prevalence and severity of fleaborne typhus and of the importance of early doxycycline therapy is essential for prevention and treatment efforts.

Identifiants

pubmed: 37535465
doi: 10.15585/mmwr.mm7231a1
pmc: PMC10414999
doi:

Substances chimiques

Doxycycline N12000U13O

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

838-843

Déclaration de conflit d'intérêts

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Sharon Balter reports serving on the executive committee of the California Association of Disease Controllers. No other potential conflicts of interest were disclosed.

Références

Clin Infect Dis. 2008 Mar 15;46(6):913-8
pubmed: 18260783
Rev Inst Med Trop Sao Paulo. 2020 Dec 18;62:e99
pubmed: 33331518
Pediatr Blood Cancer. 2007 Feb;48(2):124-31
pubmed: 16937360
Am J Trop Med Hyg. 1970 Mar;19(2):311-8
pubmed: 4986201
Annu Rev Entomol. 1990;35:553-69
pubmed: 2105686
Trop Med Infect Dis. 2020 Dec 28;6(1):
pubmed: 33379251
Am J Trop Med Hyg. 2017 May;96(5):1088-1093
pubmed: 28500797
Am J Med. 2022 Oct;135(10):e397-e398
pubmed: 35576998
Trop Dis Bull. 1978 Apr;75(4):237-317
pubmed: 705902
Lancet. 1998 Nov 21;352(9141):1709
pubmed: 9853468

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH